Table 3.
VFQ-25 | Coefficient | SE | t | p > t | (95% CI) | |
---|---|---|---|---|---|---|
Trait Anxiety | −0.64 | 0.22 | −2.93 | 0.005 | −1.07 | −0.20 |
Age | 0.61 | 0.17 | 3.48 | 0.001 | 0.26 | 0.95 |
Gender (female) | 1.53 | 2.62 | 0.59 | 0.560 | −3.69 | 6.75 |
AMD severity | ||||||
intermediate (vs. early state) | −3.56 | 3.68 | −0.97 | 0.337 | −10.91 | 3.79 |
Advance (vs. early stage) | −7.13 | 3.72 | −1.92 | 0.059 | −14.55 | 0.28 |
Years from diagnosis | 0.07 | 0.21 | 0.35 | 0.727 | −0.35 | 0.50 |
Distance visual acuity | 33.34 | 4.71 | 7.08 | <0.001 | 23.95 | 42.73 |
Contrast Sensitivity | 13.89 | 4.88 | 2.85 | 0.006 | 4.15 | 23.64 |
SE: Spherical Equivalent; AMD: Age Macular Degeneration; CI: Confidence Interval. Values in bold means statistical significance.